Forwarded from Facts Matter with Roman Balmakov
This media is not supported in your browser
VIEW IN TELEGRAM
#Merck & Co. is set to receive $712 per treatment course for its #COVID19 #AntiviralPill from the U.S. government—even though it costs a fraction of that amount to produce and is reportedly on track for a price of $12 in India.
🔥Watch here👉https://youtu.be/0_mCj8DZ-4w
🔥Watch here👉https://youtu.be/0_mCj8DZ-4w